07:00 , Apr 25, 2016 |  BC Week In Review  |  Company News

Allenex, CareDx deal

CareDx acquired fellow transplant diagnostic company Allenex. For each Allenex share held, majority shareholders received 0.01458 CareDx shares, SEK1.191 in cash and a separate cash payment of SEK0.540, which is deferred until March 31, 2017....
07:00 , Sep 2, 2013 |  BC Week In Review  |  Clinical News

XM-ONE regulatory update

Allenex said Mexico approved XM-ONE to detect human leukocyte antigen (HLA) and non-HLA antibodies between donor and recipient in organ transplantations. Allenex immediately launched XM-ONE in Mexico. Allenex's AbSorber AB subsidiary already markets XM-ONE...
07:00 , Sep 2, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Allenex AB (SSE:ALNX) gained SEK1.03 (48%) to SEK3.19 on Thursday after saying Mexico approved XM-ONE to detect human leukocyte antigen (HLA) and non-HLA antibodies between donor and recipient in organ transplantations. XM-ONE is an endothelial...
07:00 , Jun 17, 2013 |  BC Week In Review  |  Company News

Allenex management update

Allenex AB (SSE:ALNX), Stockholm, Sweden   Business: Transplant   Resigned: Michael Petruny as general manager of Allenex's Olerup Inc. subsidiary; he will be replaced by Anders Karlsson, CEO of Allenex and Olerup, until a replacement is identified...
07:00 , Jun 10, 2013 |  BC Week In Review  |  Company News

Allenex, AnaMar deal

This month, Allenex will sell its 2.1% equity stake in AnaMar to AnaMar's main owner Koncentra Holding AB (Stockholm, Sweden) for SEK1.7 million ($256,581). Allenex became an owner in AnaMar in 1998. Allenex said it...
07:00 , May 20, 2013 |  BC Week In Review  |  Company News

Allenex, ONCOlog Medical QA AB other news

Allenex said ONCOlog has filed for bankruptcy. Allenex, which owns 14.9% of ONCOlog, said its financial results will not be affected because it has not financed ONCOlog since mid-2011 and already values its holding in...
07:00 , May 6, 2013 |  BC Week In Review  |  Financial News

Allenex completes debt financing

Allenex AB (SSE:ALNX), Stockholm, Sweden   Business: Transplant   Date completed: 4/25/13   Type: Debt financing   Raised: SEK90 million ($13.7 million)   Investors: Danske Bank A/S; FastPartner AB; and an individual investor   Note: Allenex received a SEK70 million ($10.6...
08:00 , Feb 11, 2013 |  BC Week In Review  |  Company News

Allenex transplant, diagnostic news

Allenex received €215,000 ($292,293) as part of a €2.6 million ($3.6 million) award from the EU's Seventh Framework Program (FP7) to the EUROSTAM consortium of European Transplant Centers, which aims to enhance transplantation in patients...
07:00 , Jun 4, 2012 |  BC Week In Review  |  Clinical News

XM-ONE: Postmarketing study started

Allenex (formerly LinkMed AB) said Tulane University's Tulane Medical Center began an investigator-sponsored, prospective trial to evaluate XM-ONE before and 6 months after transplantation in about 100 kidney transplant patients. Allenex's AbSorber AB subsidiary already...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Company News

Allenex, Xenella deal

Transplant company Allenex said Xenella (formerly Godcup 7154 AB) acquired 11.2 million shares (9.3%) at SEK1.50 per share, or SEK16.8 million ($2.4 million), in a mandatory cash tender offer. The offer was triggered by...